22NW, LP 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
22NW, LP disclosed 21 US equity positions worth $158.8m in its Q2 2025 13F filing. The largest position was FSTR at 18.1% of the reported book, followed by LFCR and ANEB. Against the Q1 2025 filing, it opened 6 new positions, added to 7 and reduced 1 among the top 21 holdings.
What did 22NW, LP own in Q2 2025? Top 21 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | FSTR FOSTER L B CO | Industrials | 18.1% | $28.7m | 1,313,121 | 0% | held |
| 2 | LFCR LIFECORE BIOMEDICAL INC | 14.2% | $22.6m | 264,180 | -85% | reduced | |
| 3 | ANEB ANEBULO PHARMACEUTICALS INC | 14.0% | $22.3m | 15,467,300 | 0% | held | |
| 4 | SRI STONERIDGE INC | Consumer Cyclical | 8.6% | $13.7m | 1,943,508 | 19% | added |
| 5 | DHX DHI GROUP INC | Technology | 6.2% | $9.8m | 3,299,937 | 27% | added |
| 6 | RGNX REGENXBIO INC | Healthcare | 4.8% | $7.6m | 923,679 | 38% | added |
| 7 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 4.8% | $7.6m | 560,042 | 21% | added |
| 8 | CULP CULP INC | 4.6% | $7.3m | 1,859,061 | 0% | held | |
| 9 | PHENIXFIN CORP | 3.8% | $6.0m | 117,885 | 0% | held | |
| 10 | UFI UNIFI INC | Consumer Cyclical | 3.2% | $5.1m | 981,535 | 34% | added |
| 11 | MGTX MEIRAGTX HLDGS PLC | 2.4% | $3.8m | 586,519 | – | new | |
| 12 | NKTR NEKTAR THERAPEUTICS | Healthcare | 2.4% | $3.8m | 146,115 | – | new |
| 13 | CMT CORE MOLDING TECHNOLOGIES IN | 2.0% | $3.2m | 191,222 | – | new | |
| 14 | TISI TEAM INC | 2.0% | $3.1m | 171,090 | 391% | added | |
| 15 | ARVN ARVINAS INC | Healthcare | 1.9% | $3.0m | 413,533 | – | new |
| 16 | FB1 FARMER BROS CO | 1.7% | $2.7m | 1,955,526 | 0% | held | |
| 17 | MEC MAYVILLE ENGR CO INC | 1.6% | $2.5m | 155,450 | – | new | |
| 18 | CMPS COMPASS PATHWAYS PLC | Healthcare | 1.6% | $2.5m | 882,844 | 37% | added |
| 19 | ELDN ELEDON PHARMACEUTICALS INC | 1.1% | $1.7m | 636,364 | 0% | held | |
| 20 | SSKN STRATA SKIN SCIENCES INC | 0.8% | $1.2m | 536,995 | 0% | held | |
| 21 | PSYCHEMEDICS CORPORATION CMN | 0.4% | $618.3k | 276,034 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.